DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 10/29/2026 declared a dividend of $0.8200 per share

Gilead Sciences Inc (NASDAQ:GILD) on 10/29/2026 declared a dividend of $ 0.8200 per share payable on December 30, 2026 to shareholders of record as of December 15, 2026.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 2.0603015423% and has increased its dividends for 10 successive years.

Gilead Sciences Inc's market cap is $ 197,400,836,000 and has a PE ratio of 0.00. The stock price closed yesterday at $ 159.20 and has a 52 week low/high of $ 114.02 and $ 160.83.

Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries.

For more information on Gilead Sciences Inc click here.